OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review
Yazan Samhouri, Sorana G Ursu, Nina Dutton, et al.
Journal of Oncology Pharmacy Practice (2020) Vol. 27, Iss. 4, pp. 990-995
Closed Access | Times Cited: 22
Yazan Samhouri, Sorana G Ursu, Nina Dutton, et al.
Journal of Oncology Pharmacy Practice (2020) Vol. 27, Iss. 4, pp. 990-995
Closed Access | Times Cited: 22
Showing 22 citing articles:
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, et al.
Blood Research (2023) Vol. 58, Iss. S1, pp. S90-S95
Open Access | Times Cited: 19
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, et al.
Blood Research (2023) Vol. 58, Iss. S1, pp. S90-S95
Open Access | Times Cited: 19
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 26
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 26
Blastic plasmacytoid dendritic cell neoplasm (BPDCN ): A promising future in the era of targeted therapeutics
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council
Nasir Bakshi, Ayman Hejazi, Hatim Al-Maghraby, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 221-221
Open Access
Nasir Bakshi, Ayman Hejazi, Hatim Al-Maghraby, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 221-221
Open Access
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, et al.
Leukemia Research (2024) Vol. 139, pp. 107479-107479
Closed Access | Times Cited: 2
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, et al.
Leukemia Research (2024) Vol. 139, pp. 107479-107479
Closed Access | Times Cited: 2
Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
Philipp Faustmann, Jan C. Schroeder, Lucas Mix, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Philipp Faustmann, Jan C. Schroeder, Lucas Mix, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment
Xiaoning Wang, Jiashuo Guo, Yan Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Xiaoning Wang, Jiashuo Guo, Yan Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Hypermethylation of the Promoter of miR-338-5p Mediates Aberrant Expression of ETS-1 and Is Correlated With Disease Severity Of Astrocytoma Patients
Junping Wang, Cheng Huo, Jinzhu Yin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Junping Wang, Cheng Huo, Jinzhu Yin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature
Nil Albiol, Silvana Novelli, Anna Mozos, et al.
Journal of Medical Case Reports (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Nil Albiol, Silvana Novelli, Anna Mozos, et al.
Journal of Medical Case Reports (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Targeting CD123 in BPDCN: an emerging field
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Éric Deconinck, Priyanka Mehta, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 4, pp. e130-e137
Open Access | Times Cited: 4
Naveen Pemmaraju, Éric Deconinck, Priyanka Mehta, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 4, pp. e130-e137
Open Access | Times Cited: 4
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting
Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, et al.
Journal of Immunotherapy and Precision Oncology (2024) Vol. 7, Iss. 3, pp. 205-209
Open Access | Times Cited: 1
Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, et al.
Journal of Immunotherapy and Precision Oncology (2024) Vol. 7, Iss. 3, pp. 205-209
Open Access | Times Cited: 1
Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia
Wei Wang, Quanfang Luo, Qinpin Chen, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-4
Open Access | Times Cited: 5
Wei Wang, Quanfang Luo, Qinpin Chen, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-4
Open Access | Times Cited: 5
Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Nathaniel R. Wilson, Naveen Pemmaraju
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 4, pp. 431-438
Closed Access | Times Cited: 3
Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report
Fuyi Luo, Bingjie Li, Jing Li, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access
Fuyi Luo, Bingjie Li, Jing Li, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access
A 31-year-old male with a plasmacytoid dendritic blast cell neoplasm
Danay Caballero Hernández, Darío A Rueda, L Rapan, et al.
ecancermedicalscience (2024) Vol. 18
Open Access
Danay Caballero Hernández, Darío A Rueda, L Rapan, et al.
ecancermedicalscience (2024) Vol. 18
Open Access
Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression
Rohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Journal of Hematopathology (2021) Vol. 15, Iss. 1, pp. 35-39
Open Access | Times Cited: 3
Rohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Journal of Hematopathology (2021) Vol. 15, Iss. 1, pp. 35-39
Open Access | Times Cited: 3
Tagraxofusp Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm With Loss of CD123 Expression: Case and Review of Literature
Rohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Research Square (Research Square) (2021)
Open Access
Rohit Gulati, Asma Abu-Salah, Tareq Salous, et al.
Research Square (Research Square) (2021)
Open Access
